These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6445062)

  • 21. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
    Daw MA; Siala IM; Warfalli MM; Muftah MI
    Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital].
    Sánchez-Quijano A; Rivera F; Lissen E; Ollero M; Lozano F; García de Pesquera F; Vázquez R; Andreu-Kern F
    Med Clin (Barc); 1984 Jun; 83(1):1-3. PubMed ID: 6482541
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B virus markers in blood donors in the west of Scotland.
    Barr A; Houston SR; MacVarish IP; Dow BC; Mitchell R; Crawford RJ
    Med Lab Sci; 1981 Oct; 38(4):405-7. PubMed ID: 7329226
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of hepatitis B in the surgical clinic].
    Shalimov SA; Frolov AF; Radzikhovskiĭ AP; Orgel' MIa; Martsinkovskiĭ LT; Pokrasen NM; Shevchenko LF; Anan'ev VA; Tat'ianko NV
    Vestn Khir Im I I Grek; 1987 Jun; 138(6):133-6. PubMed ID: 3672774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On our preventive measures for posttransfusion hepatitis].
    Inoguchi K; Ikejiri T; Kurashige M; Yamaguchi K
    Shujutsu; 1965 Sep; 19(9):725-32. PubMed ID: 5885750
    [No Abstract]   [Full Text] [Related]  

  • 26. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Viral hepatitis morbidity in blood recipients].
    Grinshteĭn EA; Aleĭnik MD; Klimova NIa; Makarevich IK; Karavashkina EV
    Probl Gematol Pereliv Krovi; 1981 Jun; 26(6):16-9. PubMed ID: 7279883
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B virus infection and transfusion medicine: science and the occult.
    Hollinger FB
    Transfusion; 2008 May; 48(5):1001-26. PubMed ID: 18454738
    [No Abstract]   [Full Text] [Related]  

  • 29. A prospective study of posttransfusion hepatitis B virus infection.
    Wang D; Tan D; Cao X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):77-9. PubMed ID: 11503032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proceedings: Prophylaxis of post-transfusion hepatitis (author's transl)].
    Deicher H
    Thoraxchir Vask Chir; 1973 Oct; 21(5):363-9. PubMed ID: 4131107
    [No Abstract]   [Full Text] [Related]  

  • 31. [HBs-antigen and blood transfusion (author's transl)].
    Andre A; Brocteur J; Donea B; Proveux M
    Acta Gastroenterol Belg; 1977; 40(5-6):222-35. PubMed ID: 920043
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of type B hepatitis.
    Hoofnagle JH
    Gastroenterology; 1979 Jun; 76(6):183-5. PubMed ID: 437452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Post-transfusion hepatitis. Effects of long-term screening for HBsAg carriers among blood donors].
    Pintera J
    Cas Lek Cesk; 1982 Sep; 121(37):1148-52. PubMed ID: 7139671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state].
    Pintera J; Krácmar C
    Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178
    [No Abstract]   [Full Text] [Related]  

  • 35. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B surface antigen carriers among hospital personnel: (a sero-study in Government General Hospital, Madras).
    Thyagarajan SP; Subramanian S; Sundaravelu T; Sivakumar S; Prasad PR; Thiruvengadam KV
    J Assoc Physicians India; 1982 Nov; 29(11):941-5. PubMed ID: 7130112
    [No Abstract]   [Full Text] [Related]  

  • 37. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 38. [Post-transfusion hepatitis].
    Frey-Wettstein M
    Schweiz Med Wochenschr Suppl; 1980; (10):1-40. PubMed ID: 6769160
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of post-transfusion hepatitis. I. Evaluation of the effectiveness of donor selection by the test for HBsAg].
    Bondarenko MP; Stepanov GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):44-8. PubMed ID: 7269917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk of posttransfusion hepatitis in hemophilia patients].
    Margolina AN; Somova AV; Golosova TV; Pliushch OP; Andreev IuN
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):46-8. PubMed ID: 7367412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.